Table 1.
Work-up for radioembolization.
| Minimal work-up | Additional work-up | |||
|---|---|---|---|---|
| Clinical assessment | Patient level of functioning | ECOG performance score | Fibroscan/gastroscopy | Assess esophageal varices |
| Signs of hepatic dysfunction | Child-Pugh or MELD score | |||
| NET hormone-related symptoms | Assessment of clinical response | |||
| Blood work | Liver function | Bilirubin, ALP, AST, ALT, albumin | Hb, hematocrit, WBC, platelets | Assess anemia or bleeding disorders |
| Kidney function | Creatinine, eGFR; for angiography | |||
| Tumor markers | Assessment of biochemical response | |||
| Coagulation assessment | E.g., prothrombin time or INR; for angiography | |||
| Imaging studies | GdMRI/contrast-enhanced CT | Assess intrahepatic tumor load | SSTR-PET-CT | Assess total body tumor load |
| Early contrast-enhanced CT | Assess liver arterial vascularization | FDG-PET-CT | Assess tumor grade distinction and exclusion aggressive disease | |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; NET, neuroendocrine tumor; ALP, alkaline phosphatase; AST, aspartate aminotransferase; ALT, alanine; eGFR, estimated glomerular filtration rate; CgA, chromogranin A; INR, international normalized ratio; GdMRI, gadolinium-enhanced magnetic resonance imaging; CT, computed tomography; Hb, hemoglobin; WBC, white blood count; SSTR, somatostatin receptor; PET, positron emission tomography; FDG, fluorodeoxyglucose.
This work is licensed under a